Searched for
IBUPROFEN API
IOL Chemicals announces 1:5 stock split; record date soonIOL Chemicals has approved a 1:5 stock split. This will increase affordability and liquidity. Shareholders will receive 5 new shares for ev...
US FDA inspects Vishakhapatnam facility of Solara Active PharmaThe US Food and Drug Administration (FDA) completes inspection of Solara Active Pharma Sciences' API manufacturing facility in Visakhapatna...
IOL Chemicals gets EDQM certification for API supply to EuropeThe European Directorate for the Quality of Medicines & HealthCare (EDQM) is a mandatory certification for distribution of any API/ pharma ...
IOL to diversify its API and specialty chemicals portfolios to boost salesThe Ludhiana-based company generates about 30% of its ₹2,216 crore revenues from the commodity API ibuprofen, where it is vertically integr...
Rahul Sharma is betting on Lemon Tree, LGB and IOL Chemicals. Here’s why“Hotel stocks have rallied well but Lemon Tree has not participated though it has really good potential to go beyond these levels.”
Covid-19 outbreak: Pharma companies airlift inputs to deal with supply disruptionsConsidering the criticality in respect of Active Pharmaceutical Ingredients (APIs) and Key Starting Material (KSMs), the companies have sta...
After 1,800% jump in 10 years, this pharma stock is in no mood to haltThe company is one of the active ingredients and drug formulations makers.
Strides Shasun gets USFDA nod for generic Ibuprofen capsulesThe generic Ibuprofen capsules, 200 mg, is meant for relieving pain and will be manufactured at the company's oral dosage facility in Banga...
26% dip in drug ingredient import from ChinaIn 2017, India imported 354 Active Pharmaceutical Ingredients (APIs) from China, a 26% dip compared to 447 in 2015.
Granules India's net profit up 26 pc to Rs 41 cr in Q2The company's revenue increased by 3 per cent at Rs 364 crore as compared to Rs 353 crore in the corresponding period.
India dependent on China for 12 drugs on National List of Essential Medicines: GovernmentIndia is largely dependent on China for imports of drug ingredients of 12 essential drugs which are in National List of Essential Medicines...
- We can solve the Chinese pharma puzzle: C Krishna Prasad, MD, Granules Pharma
In a couple of years from now, China will be the third-largest pharmaceutical market in the world making medicines worth $40 billion.
- Granules India to augment APIs production, expand market share of best sellers
Granules India that engages in manufacturing and supplying active pharmaceutical ingredients will expand its API and pharmaceutical formula...
- Reliance, Mylan, Ranbaxy eye Shasun’s API business
Mukesh Ambani's Reliance Pharma could vie with global giants Mylan and Ranbaxy in bidding for Shasun's Rs 400-crore API business. Bring hom...
- Granules India targets overseas buys
Drug maker Granules India is looking for acquisitions or partnerships in China, Greece, Malta and South Africa to expand capacity and boost...
- IFC acquires 11.8% in Granules India for Rs 60 cr
The International Financial Corporation (IFC) has picked up 11.8% stake in Granules India (GIL), a mid-sized pharmaceutical firm, for $15 m...
- Granules India to raise 20 mn dollars
Pharmaceutical formulation intermediates manufacturer, Granules India on Wednesday said it will consider raising up to 20 million dollar th...